Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (24)

2023

  1. The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification

    Infection and immunity, Vol. 91, Núm. 2, pp. e0001223

2022

  1. Correction to: Evaluation of CHROMagar™-Serratia agar, a new chromogenic medium for the detection and isolation of Serratia marcescens (European Journal of Clinical Microbiology & Infectious Diseases, (2021), 40, 12, (2593-2596), 10.1007/s10096-021-04328-w)

    European Journal of Clinical Microbiology and Infectious Diseases

  2. Evaluation of different phenotypic methods to detect methicillin resistance in Staphylococcus aureus isolates recovered from cystic fibrosis patients

    Diagnostic Microbiology and Infectious Disease, Vol. 102, Núm. 1

  3. The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives

    Microorganisms, Vol. 10, Núm. 4

2021

  1. Evaluation of CHROMagar™-Serratia agar, a new chromogenic medium for the detection and isolation of Serratia marcescens

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 12, pp. 2593-2596

2020

  1. A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis

    Cells, Vol. 9, Núm. 4

  2. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

  3. Prevalence and risks factors associated with ESBL-producing faecal carriage in a single long-term-care facility in Spain: emergence of CTX-M-24- and CTX-M-27-producing Escherichia coli ST131-H30R

    The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 9, pp. 2480-2484

2019

  1. Helicobacter pylori seroprevalence in Spain: Influence of adult and childhood sociodemographic factors

    European Journal of Cancer Prevention, Vol. 28, Núm. 4, pp. 294-303

  2. Influence of a Serratia marcescens outbreak on the gut microbiota establishment process in low-weight preterm neonates

    PLoS ONE, Vol. 14, Núm. 5

  3. Phylogenomics of Enterococcus faecalis from wild birds: new insights into host-associated differences in core and accessory genomes of the species

    Environmental Microbiology, Vol. 21, Núm. 8, pp. 3046-3062

  4. Serratia marcescens colonization in preterm neonates during their neonatal intensive care unit stay

    Antimicrobial Resistance and Infection Control, Vol. 8, Núm. 1

2017

  1. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341

  2. Bacterial Diversity of the Gastric Content of Preterm Infants during Their First Month of Life at the Hospital

    Frontiers in Nutrition, Vol. 4

  3. Gut microbiota and systemic inflammation changes after bread consumption: The ingredients and the processing influence

    Journal of Functional Foods, Vol. 32, pp. 98-105

2016

  1. Association of Streptococcus gallolyticus subspecies gallolyticus with colorectal cancer: Serological evidence

    International Journal of Cancer, Vol. 138, Núm. 7, pp. 1670-1679

2015

  1. In vivo attenuation and genetic evolution of a ST247-SCCmecI MRSA clone after 13 years of pathogenic bronchopulmonary colonization in a patient with cystic fibrosis: Implications of the innate immune response

    Mucosal Immunology, Vol. 8, Núm. 2, pp. 362-371

  2. Preterm infant gut colonization in the neonatal ICU and complete restoration 2 years later

    Clinical Microbiology and Infection, Vol. 21, Núm. 10, pp. 936.e1-936.e10

  3. Response to "In vivo attenuation and genetic evolution of a ST247-SCCmecI MRSA clone after 13 years of pathogenic bronchopulmonary colonization in a patient with cystic fibrosis: Implications of the innate immune response"

    Mucosal Immunology

2014

  1. First report of macrolide resistance in a mycoplasma pneumoniae isolate causing community-acquired pneumonia in Spain

    Antimicrobial Agents and Chemotherapy